WHY IT MATTERS: If Kansas passes medical cannabis legislation, patients currently traveling to neighboring states or going without treatment may soon be able to access cannabis-based therapies legally and closer to home. CLINICAL OVERVIEW: Kansas is considering legislation that would establish both medical and recreational cannabis frameworks, representing a significant shift for one of the few remaining states with no legal cannabis access. The medical proposals include pathways for patients with qualifying conditions to access cannabis-based treatments under physician supervision, while rescheduling efforts at the federal level have created new momentum for states like Kansas to act.
Legislation on medical cannabis: DOH bares conditions – Cebu Daily News
WHY IT MATTERS: Filipino patients with conditions like chronic pain, epilepsy, or cancer-related symptoms may soon have a clearer legal pathway to access medical cannabis, but only if proposed legislation meets the scientific standards regulators are demanding. CLINICAL OVERVIEW: Medical cannabis legislation in the Philippines is advancing through regulatory channels, with health authorities emphasizing that any framework for legal access must be grounded in robust clinical and scientific evidence. This position reflects a cautious but scientifically oriented approach to policy, requiring that efficacy and safety data drive decisions rather than anecdotal reports or political pressure.
House panel revives medical cannabis bill – Daily Tribune
WHY IT MATTERS: Patients in the Philippines with conditions like epilepsy, chronic pain, or cancer-related symptoms who currently have no legal access to cannabinoid therapies may gain a regulated pathway to these treatments if this bill advances to full legislative approval and enactment. CLINICAL OVERVIEW: The Philippines is advancing legislation to permit medical cannabis, with House committees on health and dangerous drugs giving approval to a consolidated bill that would establish a regulated framework for therapeutic use. This represents a significant shift in a country that has historically maintained strict anti-drug policies, including severe penalties under the Comprehensive Dangerous Drugs Act.
House panel approves proposed medical cannabis law – POLITIKO
WHY IT MATTERS: If this medical cannabis law passes in the Philippines, patients with qualifying conditions may gain legal access to cannabis-based treatments that were previously unavailable or carried serious legal risk. CLINICAL OVERVIEW: The Philippine House of Representatives has moved forward with proposed legislation that would formalize a medical cannabis framework, focusing on expanding research infrastructure and creating regulated pathways for patient access. This represents a significant shift in drug policy for a country that has historically maintained strict prohibitionist stances toward cannabis.
Bill to protect Nebraska physicians recommending medical cannabis advances to floor
WHY IT MATTERS: If this bill passes, Nebraska patients will have a much better chance of finding a licensed physician willing to openly discuss and recommend medical cannabis without fear of losing their medical license. CLINICAL OVERVIEW: Physician protection legislation in Nebraska addresses a longstanding barrier to medical cannabis access: the fear among doctors that recommending cannabis could expose them to professional or legal consequences under state licensing boards. Without such protections, many qualified physicians avoid cannabis consultations entirely, leaving patients without informed medical guidance even in states where the therapy is legal.
Observational study on medical marijuana use seeks Arizona participants – KJZZ
WHY IT MATTERS: Arizona adults who are about to start using cannabis for a medical condition have a time-sensitive opportunity to contribute to national research that could directly shape how physicians recommend and dose cannabis for patients like them. CLINICAL OVERVIEW: Observational research on medical cannabis is essential for building the real-world evidence base that controlled trials alone cannot provide, particularly given the diversity of conditions, products, and consumption patterns patients bring to clinical settings. Recruiting participants at the point of initiation allows researchers to capture baseline data and track outcomes longitudinally, which strengthens the quality of findings compared to studies that enroll patients already well into their cannabis use.
Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief
WHY IT MATTERS: Patients using cannabis for appetite stimulation, including those managing cachexia or chemotherapy-related anorexia, now have stronger neurological evidence supporting what clinicians have observed for years, which may help guide more targeted and confident therapeutic use. CLINICAL OVERVIEW: The appetite-stimulating effects of cannabis, commonly known as “the munchies,” have long been observed clinically but the precise neurological mechanisms were not well characterized until recently. Research has now identified how cannabinoids interact with specific brain circuits to drive increased appetite, independent of the type or palatability of food available.
Scientists are raising new concerns about marijuana use in teens – KPBS
WHY IT MATTERS: For parents and adolescents, this research reinforces that cannabis is not a low-risk substance during the teenage years, and decisions about use should be made with full awareness of the potential for lasting mental health consequences. CLINICAL OVERVIEW: Research continues to build a concerning picture around adolescent cannabis use and its association with elevated risk for psychiatric conditions, including psychosis, depression, and anxiety disorders. The developing brain, particularly during the teenage years, appears to be especially vulnerable to the neurochemical disruptions that cannabinoids can produce, with THC’s interaction with the endocannabinoid system potentially altering normal neurodevelopmental trajectories.
Top of the Feed: Policy Momentum, Patient Safety, and the Science Still Catching Up – February 25, 2026
A synthesis of 5 featured cannabis articles from 22 reviewed — key themes, clinical context, and Dr. Caplan’s take from the latest feed update on February 25, 2026.
In the Mix: 15 More Articles — February 25, 2026
15 cannabis articles reviewed and scored below the CED clinical relevance threshold in the February 25, 2026 feed update. Summaries and source links included.